Reneuron Group Plc

Reneuron (RENE)

Buy
Sell
Company name:Reneuron Group Plc
EPIC:RENETrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BF5G6K95
Market Segment:ASQ1Share Type:DE
WWW Address:http://www.reneuron.com/Description:ORD 1P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 139.50 images.advfn.com/imagesnew/2/gb/up 2.0 [1.45] 138.00 144.00 137.50 141.00 135.00 105,768
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 79.31 56.86 -0.01 -35.90 - - - 173.00 - 72.50

Reneuron Key Figures

(at previous day's close)
Market Cap.79.31m
Shares In Issue56.86m
Prev. Close137.50
PE Ratio- 
Dividend Yield-%
EPS - basic-35.90p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-25.16p
Return On Equity (ROE)-86.30%
Operating Margin-228.49%
PEG Factor- 
EPS Growth Rate20.58%
Dividends PS Growth Rate-%
Net Debt-5.47m
Gross Gearing35.11%
Quick Assets19.15m
Net Working Capital12.70m
Intangibles / Fixed Assets63.22%
Turnover PS10.67p
Pre-Tax Profit PS-24.37p
Retained Profit PS-20.07p
Cash PS22.21p
Net Cash PS10.87p
Net Tangible Asset Value PS *21.89p
Net Asset Value PS23.26p
Spread6.00 (4.17%) 
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Reneuron Balance Sheet

L^RENE:Liabilities+EQL^RENE:Assets

Share Price Performance

Sample Period †HighLow
1 week145.00115.00
4 weeks145.00102.50
12 weeks145.0096.50
1 year173.0072.50

Share Price Chart (5 years)

Reneuron Historic Returns

Period †OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week118.5021.0017.72115.000.20133.19
4 weeks102.5037.0036.10102.500.17122.35
12 weeks133.006.504.8996.500.24114.85
26 weeks93.5046.0049.2072.500.23105.32
1 year173.00-33.50-19.3672.500.14108.10
3 years77.5062.0080.0047.000.13139.33
5 years300.00-160.50-53.501.451.09219.50
† periods calculated are whole weeks rather than calendar months

Reneuron Key Management Ratios

Reneuron Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 3.10 
Tobin's Q Ratio (excl. intangibles)3.16 
Dividend Yield-%
Market-to-Book Ratio6.00 
Price-to-Pre-Tax Profit PS-5.72 
Price-to-Retained Profit PS-6.95 
Price-to-Cash Flow PS-5.54 
Price-to-Sales PS13.08 
Price-to-Net Tangible Asset Value PS6.37 
Price-to-Cash PS6.28 
Net Working Capital PS22.34 
Price Pct to Working Capital PS6.24%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Reneuron Financial Ratios

(Leverage Ratios)
Debt Ratio5.08%
Debt-to-Equity Ratio0.05 
Debt-to-Equity Ratio (excl. Intgbl)0.06 
Debt-to-Equity Market Value0.01 
Net Gearing-26.86%
Net Gearing (excl. Intangibles)-27.92%
Gross Gearing35.11%
Gross Gearing (excl. Intangibles)36.50%
Gearing Under 1 Year31.64%
Gearing Under 1 Year (excl. Intgbl)32.89%
Assets/Equity1.54 
Cash/Equity95.48 
(Liquidity Ratios)
Net Working Capital to Total Assets62.33%
Current Ratio2.97 
Quick Ratio (Acid Test)2.97 
Liquidity Ratio1.96 
Cash & Equiv/Current Assets65.94%
(Solvency Ratios)
Enterprise Value67.40m
CFO/Sales-2.36 
CFO/Attributable Profit- 
CFO/Assets-0.70 
CFO/Debt-2.00 
Total Debt/Equity Market Value0.09 
Total Debt/Sales1.18 
Total Debt/Pre-Tax Profit-0.52 
Total Debt7.15m
Total Debt/Net Current Assets0.56%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-13.62%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs2 
Beta (60-Mnth)Beta (36-Mnth)
-0.01150.0292

Reneuron Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-99.48%
Return On Assets (ROA)-44.56%
Net Profit Margin-188.16%
Assets Turnover0.24 
Return On Equity (ROE)-86.30%
Return On Investment (ROI)-61.11%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-188.16%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.33 
Fixed Assets Turnover1.52 
Current Assets Turnover0.28 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales4.22 
Debtors-to-Sales83.80%
Debt Collection Period305.87Days

Reneuron Dividends

Sorry No Data Available

Reneuron Fundamentals
 31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)
turnover0.05-0.04-0.05-6.07100.00%m
pre tax profit-18.17--20.97--17.18--13.86-228.49%m
attributable profit-15.57--17.62--14.29--11.41-188.16%m
retained profit-15.57--17.62--14.29--11.41-188.16%m
eps - basic (p)-49.20 -55.70 -45.20 -35.90 
eps - diluted (p)-49.20 -55.70 -45.20 -35.90 
dividends per share- - - - 

Reneuron Balance Sheet

 31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)
L^RENE:Liabilities+EQL^RENE:AssetsL^RENE:Liabilities+EQL^RENE:AssetsL^RENE:Liabilities+EQL^RENE:AssetsL^RENE:Liabilities+EQL^RENE:Assets
 31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)
ASSETS
fixed assets fixed assets0.721.23%0.731.70%0.632.05%0.452.22%m
intangibles intangibles--%0.190.44%0.190.60%0.783.81%m
fixed investments fixed investments24.9442.36%9.5022.29%5.9519.30%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks--%--%--%--%m
debtors debtors5.088.62%4.3010.08%3.6411.81%6.5232.01%m
cash & securities cash & securities28.1347.78%27.9165.49%20.4366.24%12.6361.96%m
TOTAL58.86100%42.62100%30.85100%20.38100%m
LIABILITIES
creditors - short creditors - short5.709.69%5.9513.96%7.4324.09%6.4531.64%m
creditors - long creditors - long0.000.00%--%--%0.713.47%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL5.709.69%5.9513.96%7.4324.09%7.1535.11%m
EQUITY
ord cap, reserves ord cap, reserves53.1690.31%36.6786.04%23.4275.91%13.2264.89%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL53.1690.31%36.6786.04%23.4275.91%13.2264.89%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Reneuron Cash Flow Statement

31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)
Operating CF-12.64-14.89-11.99-14.30m
Pre-Financing CF-12.65-14.74-11.84-14.12m
Retained CF10.70-0.21-7.48-7.81m

Reneuron Brokers

NameActivityTypeMnemonicCode
Collins Stewart Europe LimitedMarket Maker(MMF)Broker/DealerCSCSCSTEGB21
Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Liberum Capital LimitedMarket Maker(MMF)Broker/DealerLIBCLCAPGB21
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
LSE
RENE
Reneuron
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210414 01:53:21